Cargando…
Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study
The present study investigated outcomes of infliximab (IFX) treatment among 8 Japanese patients with various types of cancer (4 with malignant melanoma, 3 with lung cancer and 1 with renal cancer) who developed severe steroid-resistant immune-related adverse events (irAEs) in association with immune...
Autores principales: | Kadokawa, Yukio, Takagi, Mari, Yoshida, Tomoe, Tatsumi, Akitoshi, Fujita, Keiko, Inoue, Takako, Ohe, Shuichi, Nakai, Yasutomo, Yamamoto, Sachiko, Otsuka, Tomoyuki, Ishihara, Ryu, Isei, Taiki, Kumagai, Toru, Nishimura, Kazuo, Imamura, Fumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890436/ https://www.ncbi.nlm.nih.gov/pubmed/33680456 http://dx.doi.org/10.3892/mco.2021.2227 |
Ejemplares similares
-
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
por: Kadokawa, Yukio, et al.
Publicado: (2023) -
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
por: Nishikawa, Tatsuya, et al.
Publicado: (2022) -
Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
por: Nakai, Yasutomo, et al.
Publicado: (2021) -
A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
por: Imamura, Fumio, et al.
Publicado: (2016) -
Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report
por: Kumagai, Toru, et al.
Publicado: (2015)